COMPUGEN LTD(CGEN)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
COMPUGEN LTD (CGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CGEN at 53.9/100 on a 32-signal composite quality model, placing it at rank #1,360 of 2,962 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), COMPUGEN LTD reports quarterly revenue of $72.8M, net income of $35.3M, an operating margin of 43.0%. Top institutional holders of CGEN by reported 13-F value include SILVERARC CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, MORGAN STANLEY, based on the most recent SEC filings. CGEN trades on the Nasdaq exchange and files with the SEC under CIK 1119774. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COMPUGEN LTD directly from SEC EDGAR.
AI Quality Score
53.9/100
AI Rank
#1,360
Revenue
$72.8M
Net Income
$35.3M
Free Cash Flow
$31.3M
Operating Margin
43.0%
CGEN key financials by period
COMPUGEN LTD reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
20-F
$72.8M
$35.3M
43.0%
FY 2024
20-F
$27.9M
$-14.2M
-53.4%
FY 2023
20-F
$33.5M
$-18.8M
-38.8%
FY 2022
20-F/A
$7.5M
$-33.7M
—
FY 2021
20-F
$6.0M
$-34.2M
—
FY 2020
20-F/A
$2.0M
$-29.7M
—
Institutions holding CGEN
Institutional investors reporting a position in COMPUGEN LTD on SEC Form 13F.
